China Pharma (NYSEAMERICAN:CPHI) Stock Price Passes Above 200-Day Moving Average of $0.00

Shares of China Pharma Holdings, Inc. (NYSEAMERICAN:CPHIGet Rating) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.23. China Pharma shares last traded at $0.22, with a volume of 220,566 shares traded.

The stock has a market capitalization of $10.84 million, a P/E ratio of -2.49 and a beta of 0.25.

China Pharma (NYSEAMERICAN:CPHIGet Rating) last released its quarterly earnings results on Thursday, May 12th. The company reported ($0.02) EPS for the quarter. The firm had revenue of $1.60 million for the quarter. China Pharma had a negative return on equity of 50.83% and a negative net margin of 37.46%.

A hedge fund recently raised its stake in China Pharma stock. Renaissance Technologies LLC increased its holdings in shares of China Pharma Holdings, Inc. (NYSEAMERICAN:CPHIGet Rating) by 43.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 700,649 shares of the company’s stock after acquiring an additional 213,170 shares during the period. Renaissance Technologies LLC owned approximately 1.61% of China Pharma worth $391,000 as of its most recent SEC filing. Institutional investors own 2.64% of the company’s stock.

About China Pharma (NYSEAMERICAN:CPHI)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Further Reading

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.